Ovid Therapeutics Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
Ovid Therapeutics Inc. (OVID) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of -1.32% for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-08.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2024-03-08
- Ovid Therapeutics Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2023 was -1.32%.
- Ovid Therapeutics Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2022 was -1.26%, a 337.74% decline from fiscal 2021.
- Ovid Therapeutics Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2021 was 0.53%, a 29.33% decline from fiscal 2020.
- Ovid Therapeutics Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2020 was 0.75%, a 50.00% increase from fiscal 2019.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month |
|---|---|
| 2023-12-31 | -1.32% 10-K · filed 2024-03-08 |
| 2022-12-31 | -1.26% 10-K · filed 2024-03-08 |
| 2021-12-31 | 0.53% 10-K · filed 2023-03-13 |
| 2020-12-31 | 0.75% 10-K · filed 2022-03-15 |
| 2019-12-31 | 0.50% 10-K · filed 2021-03-15 |
| 2018-12-31 | 0.61% 10-K · filed 2020-03-11 |
| 2017-12-31 | 0.89% 10-K · filed 2019-03-07 |
| 2016-12-31 | 1.16% 10-K · filed 2018-03-29 |
| 2015-12-31 | 0.31% 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |